news, journals and articles from all over the world.
Rutgers engineers have created a tabletop device that combines a robot, artificial intelligence and near-infrared and ultrasound imaging to draw blood or insert catheters to deliver fluids and drugs. Their research results, published in the journal Nature Machine Intelligence, suggest that autonomous systems like the image-guided robotic device could outperform people on some complex medical tasks.
The National Science Foundation has recognized Fabrizio Sergi, assistant professor of biomedical engineering at the University of Delaware, with its CAREER award to support fundamental research in motor control. His work is seeking to help those with movement disorders and identify robot-based interventions.
Electrospun synthetic cell scaffolds are not only more consistent than animal cells for cancer research, they hold the potential to replace animal testing.
Rutgers biomedical engineers have developed a “bio-ink” for 3D printed materials that could serve as scaffolds for growing human tissues to repair or replace damaged ones in the body. Their study was published in the journal Biointerphases.
In the future, robots could take blood samples, benefiting patients and healthcare workers alike. A Rutgers-led team has created a blood-sampling robot that performed as well or better than people, according to the first human clinical trial of an automated blood drawing and testing device.
Researchers from Aalto University, the University of São Paulo and the University of British Columbia have found a way to make a new kind of fibre from a combination of chitin nanoparticles, extracted from residual blue crab shells and alginate, a compound found in seaweed.
It would be the first treatment for “dry” age-related macular degeneration and could significantly improve treatment for wet AMD.
Wayne State University received a two-year, $725,000 R01 grant from the National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health for the development of a novel point-of-care 3D neonatal photoacoustic tomography (3D-nPAT) to improve the detection and measurement of hypoxic-ischemic in neonates without the need for sedation, radiation or radionuclides.
A nanoparticle carrier system that could eliminate the need for bone marrow transplants, which are both expensive and difficult for patients to undergo. The University of Delaware’s Emily Day, an assistant professor of biomedical engineering, is developing a platform that could treat stem cells directly without the need to remove them from the body.
Researchers have developed a way to prop up a struggling immune system to enable its fight against sepsis, a deadly condition resulting from the body’s extreme reaction to infection.
Scientists have developed a new gene-therapy technique by transforming human cells into mass producers of tiny nano-sized particles full of genetic material that has the potential to reverse disease processes.
Researchers hope to develop new imaging methods to improve the treatment of preeclampsia.
As nationwide demand for biomedical engineers continues to grow, Wichita State University is moving forward with a plan to create a doctoral program that would help fill that need.
In the Wong Laboratory for Nature Inspired Engineering, housed within the Department of Mechanical Engineering and the Materials Research Institute, researchers have developed a method that dramatically reduces the amount of water needed to flush a conventional toilet, which usually requires 6 liters.
Rutgers, The State University of New Jersey was selected as one of five new hubs under the National Institutes of Health’s Research Evaluation and Commercialization Hubs (REACH) program to speed up the translation of biomedical discoveries into commercially viable diagnostics, devices, therapeutics, and tools to improve patient care, enhance health, and train the next generation of innovators.
The IU-led center is one of only two multi-institution teams in the nation selected as part of a new federal program intended to improve, diversify and reinvigorate the Alzheimer’s disease drug development pipeline.
English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
Urdu